Personalized Medicine - Laymen's Summary and Main Message

Personalized Medicine - Laymen's Summary and Main Message

TOPIC:  Personalized Medicine - Laymen's Summary and Main Message

FOR MORE INFORMATION VISIT: IASLC Press Release about Personalized Medicine


November is Lung Cancer Awareness Month in many countries.  We are asking you to help educate the media, the public, and even your own social circles about the health threat that lung cancer poses, and the hope that new treatments are providing to change the outcome for many patients. 

Personalized Medicine  - Lay Summary and Main Messages to Communicate to Media and the Public.

  1. Lung Cancer is the #1 cancer killer in the world, killing more people than breast, colorectal and prostate cancers combined.
  2. Personalized medicine is treating the patient who has already been diagnosed with lung cancer with drugs that are predicted to be effective based on the characteristics of the tumor.
  3. For the first time in many decades, personalized medicine is providing hope to lung cancer patients for increased survival.
  4. Gene mutations, like EGFR, ALK, and others, are determined by testing the tumor of lung cancer patients. It is essential for medical providers to stay up to date on the latest developments.
  5. It is also important for patients of any race, age and smoking history diagnosed with advanced adenocarcinoma to receive tumor testing conducted by pathology experts to determine if they can benefit from these treatments. Patients should speak with their oncologist to receive more information about personalized medicine and reach out to lung cancer patient advocacy organizations for support.

Ask your interviewer:

  • Would you like me to have one of my patients with one of these mutations contact you for additional comments from the patient perspective?
  • Would you like to speak to another member of the multi-disciplinary team involved here at our institution? A pathologist, surgeon, nurse, etc.
  • Would you like to speak to additional experts who represent the International Association for the Study of Lung Cancer (IASLC), which is the only international association dedicated to the study of lung cancer?  If so, please contact Rob Mansheim ( to be directed to these experts.

Continue the Conversation:

- Copy and use the following badge in your social media profiles and email signatures for the month of November:


-  Follow IASLC on Facebook and Twitter for all the latest details and daily updates about Lung Cancer Awareness Month events and information.  Facebook and Twitter
- Join the conversation on social media using #LCAM and #LCAM14
-  View the IASLC key messages for the media on other topics featured during Lung Cancer Awareness Month
-  Download the IASLC/CAP/AMP Molecular Testing Guidelines from IASLC website.
-  Share this list of Advocacy Partners or Advocacy Events with your patients.